RBC Life Sciences Inc
OTC:RBCL
Balance Sheet
Balance Sheet Decomposition
RBC Life Sciences Inc
RBC Life Sciences Inc
Balance Sheet
RBC Life Sciences Inc
| Dec-1995 | Dec-1996 | Dec-1997 | Dec-1998 | Dec-1999 | Dec-2000 | Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
6
|
5
|
4
|
4
|
4
|
4
|
4
|
2
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
5
|
4
|
4
|
4
|
4
|
4
|
2
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
1
|
2
|
3
|
3
|
3
|
2
|
2
|
2
|
2
|
4
|
3
|
5
|
6
|
5
|
5
|
6
|
5
|
5
|
5
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
1
|
1
|
2
|
4
|
4
|
5
|
4
|
3
|
3
|
4
|
6
|
7
|
12
|
13
|
11
|
11
|
12
|
11
|
11
|
9
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
2
|
3
|
6
|
5
|
5
|
4
|
4
|
4
|
4
|
4
|
5
|
5
|
4
|
4
|
4
|
5
|
|
| PP&E Gross |
0
|
0
|
0
|
1
|
2
|
3
|
6
|
5
|
5
|
4
|
4
|
4
|
4
|
4
|
5
|
5
|
4
|
4
|
4
|
0
|
|
| Accumulated Depreciation |
0
|
1
|
0
|
1
|
1
|
2
|
1
|
2
|
2
|
3
|
3
|
4
|
2
|
2
|
2
|
2
|
3
|
3
|
4
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
1
|
2
|
3
|
3
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
1
|
2
|
3
|
3
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Total Assets |
2
N/A
|
4
+61%
|
6
+51%
|
8
+32%
|
9
+14%
|
11
+19%
|
12
+14%
|
11
-11%
|
11
-2%
|
11
+5%
|
13
+14%
|
14
+7%
|
19
+42%
|
20
+3%
|
19
-6%
|
18
-1%
|
19
+3%
|
18
-4%
|
18
-3%
|
16
-9%
|
|
| Liabilities | |||||||||||||||||||||
| Accounts Payable |
1
|
1
|
0
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
1
|
2
|
2
|
|
| Accrued Liabilities |
1
|
1
|
1
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
2
|
2
|
3
|
5
|
4
|
4
|
2
|
3
|
3
|
4
|
2
|
|
| Total Current Liabilities |
2
|
2
|
2
|
3
|
4
|
5
|
4
|
4
|
4
|
4
|
5
|
5
|
9
|
8
|
7
|
6
|
6
|
6
|
7
|
6
|
|
| Long-Term Debt |
1
|
0
|
1
|
1
|
1
|
1
|
4
|
3
|
3
|
3
|
3
|
3
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
2
-12%
|
2
+21%
|
4
+53%
|
5
+25%
|
6
+29%
|
9
+45%
|
8
-13%
|
7
-8%
|
7
-1%
|
8
+14%
|
8
+3%
|
12
+44%
|
10
-10%
|
9
-10%
|
8
-10%
|
9
+6%
|
8
-5%
|
9
+0%
|
8
-11%
|
|
| Equity | |||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
7
|
7
|
8
|
8
|
8
|
7
|
8
|
9
|
9
|
8
|
8
|
7
|
6
|
4
|
4
|
4
|
4
|
4
|
5
|
5
|
|
| Additional Paid In Capital |
7
|
9
|
12
|
12
|
12
|
12
|
12
|
12
|
13
|
13
|
13
|
13
|
13
|
13
|
14
|
14
|
14
|
14
|
14
|
14
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
2
+761%
|
4
+81%
|
4
+19%
|
4
+3%
|
5
+9%
|
4
-25%
|
3
-7%
|
4
+12%
|
4
+15%
|
5
+13%
|
5
+12%
|
8
+38%
|
9
+24%
|
9
-2%
|
10
+7%
|
10
0%
|
10
-4%
|
9
-5%
|
8
-7%
|
|
| Total Liabilities & Equity |
2
N/A
|
4
+61%
|
6
+51%
|
8
+33%
|
9
+13%
|
11
+19%
|
12
+14%
|
11
-11%
|
11
-2%
|
11
+5%
|
13
+14%
|
14
+7%
|
19
+42%
|
20
+3%
|
19
-6%
|
18
-1%
|
19
+3%
|
18
-4%
|
18
-3%
|
16
-9%
|
|
| Shares Outstanding | |||||||||||||||||||||
| Common Shares Outstanding |
12
|
12
|
1
|
14
|
14
|
14
|
14
|
14
|
20
|
20
|
20
|
20
|
21
|
22
|
22
|
22
|
22
|
2
|
2
|
2
|
|